Pulmonary elimination rate of inhaled 99m Tc-sestamibi radioaerosol is delayed in healthy cigarette smokers
Ruparelia, P, Cheow, HK, Evans, JW, Banney, L, Shankar, S, Szczepura, K, Swift, AE, Ballinger, JR, Hartman, NG, Chilvers, ER and Peters, AM 2008, 'Pulmonary elimination rate of inhaled 99m Tc-sestamibi radioaerosol is delayed in healthy cigarette smokers' , British Journal of Clinical Pharmacology, 65 (4) , pp. 611-614.
|PDF - Published Version |
Restricted to Repository staff only
Download (495kB) | Request a copy
Aim - To explore inhaled technetium-99m-labelled hexakis-methoxy-isobutyl isonitrile (99mTc-sestamibi) for quantifying pulmonary P-glycoprotein(P-gp) expression. Methods - The elimination rate from the lungs of 99mTc-sestamibi was recorded scintigraphically for 30min following inhalation as an aerosol in healthy smokers, nonsmokers and patients with lung disease. Results - 99m Tc-sestamibi elimination rates [%min-1 (SD; P vs. healthy nonsmokers)] were: healthy nonsmokers, 0.43 (0.083); healthy smokers,0.19 (0.056; P < 0.001); chronic obstructive pulmonary disease patients, 0.26 (0.077; P < 0.001). Elimination rates in three patients with interstitial lung disease were not accelerated. Cconclusion - Cigarette smoke upregulates lung P-gp. 99mTc-sestamibi elimination in normal smokers could be used to test new P-gp modulators. The findings also have implications for inhaled drug delivery.
|Uncontrolled Keywords:||99m Tc-sestamibi, aerosol, chronic obstructive pulmonary disease, lungs, P-glycoprotein, smoking|
|Themes:||Health and Wellbeing|
|Schools:||Colleges and Schools > College of Health & Social Care|
Colleges and Schools > College of Health & Social Care > School of Health Sciences
|Journal or Publication Title:||British Journal of Clinical Pharmacology|
|Depositing User:||RH Shuttleworth|
|Date Deposited:||16 May 2011 11:25|
|Last Modified:||18 Aug 2014 12:03|
Actions (login required)
|Edit record (repository staff only)|